1. Home
  2. VIRC vs CRDL Comparison

VIRC vs CRDL Comparison

Compare VIRC & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virco Manufacturing Corporation

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.51

Market Cap

114.0M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
CRDL
Founded
1950
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
97.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VIRC
CRDL
Price
$6.51
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
55.5K
691.7K
Earning Date
12-08-2025
11-13-2025
Dividend Yield
1.49%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$201,942,000.00
N/A
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.56
N/A
P/E Ratio
$27.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$0.77
52 Week High
$12.09
$1.59

Technical Indicators

Market Signals
Indicator
VIRC
CRDL
Relative Strength Index (RSI) 37.88 48.25
Support Level $6.62 $0.88
Resistance Level $6.93 $1.12
Average True Range (ATR) 0.29 0.08
MACD -0.04 0.01
Stochastic Oscillator 37.93 58.33

Price Performance

Historical Comparison
VIRC
CRDL

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: